A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitals

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 24, Issue 1, 2013, Pages 22-26

  Jacobs, Philip ^a   Lier, Douglas ^b   Gooch, Katherine ^c   Buesch, Katharina ^d   Lorimer, Michelle ^e   Mitchell, Ian ^f  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c ABBOTT LABORATORIES   (United States)

^d Abbott Scandinavia AB   (Sweden)

^e Lorimer Enterprises Inc   (United States)

^f ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Nosocomial infection; Pediatrics; Respiratory syncytial virus

Indexed keywords

ARTICLE; CANADA; CASE MIX; COST OF ILLNESS; EVIDENCE BASED PRACTICE; HEALTH INSURANCE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PURCHASING; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INFANT; INFECTION CONTROL; INFECTION PREVENTION; LENGTH OF STAY; PHYSICIAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIMULATION; TARGET VARIABLE;

EID: 84878328721     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/916769     Document Type: Article

References (26)

1. Karron RA. Respiratory syncytial virus and parainfluenza virus vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines, 5th edn. Philadelphia: Saunders-Elsevier 2008;1283-93.
2. Welliver RC, Checchia PA, Bauman JH, Fernandes AW, Mahadevia PJ, Hall CB. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Curr Med Res Opin 2010;26:2175-81.
3. Centers for Disease Control and Prevention. Respiratory syncytial virus activity - United States, July 2008-December 2009. Morb Mortal Wkly Rep 2010;59:230-3.
4. Langley JM, Wang EE, Law BJ, Stephens D, Boucher FD, Dobson S. Economic evaluation of respiratory syncytial virus infection in Canadian children: A Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr 1997;131:113-7. (Pubitemid 27498318)
5. Schanzer DL, Langley JM, Tam TW. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J 2006;25:795-800. (Pubitemid 44334824)
6. World Health Organization. Prevention of Hospital-acquired Infections: A Practical Guide, 2nd edn. Malta: World Health Organization Department of Communicable Disease. WHO/CDS/CSR/EPH/2002.12.
7. Simon A, Müller A, Khurana K, et al DSM RSV Paed Study Group. Nosocomial infection: A risk factor for a complicated course in children with respiratory syncytial virus infection - results from a prospective multicenter German surveillance study. Int J Hyg Environ Health 2008;211:241-50. (Pubitemid 351847846)
8. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al Pediatric Prevention Network. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr 2002;140:432-8. (Pubitemid 34494315)
9. Thorburn K, Kerr S, Taylor N, van Saene HK. RSV outbreak in a paediatric intensive care unit. J Hosp Infect 2004;57:194-201. (Pubitemid 38967327)
10. Zoutman DE, Ford D, Bryce E, et al Canadian Hospital Epidemiology Committee; Canadian Nosocomial Infection Surveillance Program; Health Canada. The state of infection surveillance and control in Canadian acute care hospitals. Am J Infect Control 2003;31:266-73. (Pubitemid 36960662)
11. Alberta Health and Wellness. Alberta Case Cost Report For 2005/06 Hospital Activity. Annual Report. Edmonton: Government of Alberta, 2008.
12. Kuzik BA, Al-Qadhi SA, Kent S, et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 2007;151:266-70.
13. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98.
14. Alberta Health Care Insurance Plan. Schedule of Medical Benefits (Procedures and Price List). Edmonton: Government of Alberta, 2007.
15. Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM. Nosocomial respiratory syncytial virus infections: The cost-effectiveness and cost-benefit of infection control. Pediatrics 2000;106:520-6. (Pubitemid 30664138)
16. Kilgore ML, Ghosh K, Beavers CM, Wong DY, Hymel PA Jr, Brossette SE. The costs of hospital-acquired infections. Med Care 2008;46:101-4.
17. Langley JM, LeBlanc JC, Wang EE, et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Pediatrics 1997;100:943-6. (Pubitemid 27516477)
18. Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers - (CPI-U). All Items Indexes and Annual Percent Changes From 1913 to Present. Washington, DC: US Department of Labor, 2011.
19. OECD. StatExtracts. Monthly Comparative Price Levels. Paris: Organisation for Economic Co-operation and Development, 2011.
20. Statistics Canada. The Consumer Price Index (62-001-XWE). Ottawa: Statistics Canada, 2010.
21. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J 2004;23:990-4. (Pubitemid 40824286)
22. Lanctôt KL, Masoud ST, Paes BA, et al. The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: A Canadian-based analysis. Curr Med Res Opin 2008;24:3223-37.
23. Statistics Canada. Estimates of Population, by Age Group and Sex for July 1, Canada, Provinces and Territories (Table 051-0001). Ottawa: Statistics Canada, 2009.
24. Madge P, Paton JY, McColl JH, Mackie PLK. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992;340:1079-83.
25. World Health Organization. Prevention of Hospital-Acquired Infections: A Practical Guide. World Health Organization Department of Communicable Disease. WHO/CDS/CSR/EPH/2002.12
26. Goldman DA. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg Infect Dis 2001;7:249-53.